Literature DB >> 10874716

Onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments.

A J Trees1, S P Graham, A Renz, A E Bianco, V Tanya.   

Abstract

The bovine parasite Onchocerca ochengi is a nodule-dwelling filarial nematode, closely related to O. volvulus, the causal agent of human River Blindness, and, sharing with it, the same vector. This brief review, based on a presentation at the BSP Autumn Symposium 1999, describes recent work supported by the WHO Drug Development Research Macrofil programme and the Edna McConnell Clark Foundation vaccine development programme, to research the chemotherapy and immunology of onchocerciasis utilising this model system, with experimental infections in Liverpool and field infections in northern Cameroon. In a series of chemotherapeutic trials involving 10 compounds in 20 treatment regimes, the comparability of drug efficacy against O. ochengi with that described against O. volvulus has been demonstrated. Repeated, long-term treatment with oxytetracycline has been shown to be macrofilaricidal and the effect is hypothesized to be related to action on Wolbachia endobacteria, abundant in O. ochengi. Avermectins/milbemycins are not macrofilaricidal (even in high and repeated long-term treatments) but induce sustained abrogation of embryogenesis. In prospective, field exposure experiments with naive calves, prophylactic treatments with ivermectin and moxidectin prevented the development of adult worm infection, raising the possibility that drug-attenuated larval challenge infections may induce immunity. Putatively immune adult cattle exist in endemically exposed populations, and these have been shown to be significantly less susceptible to challenge than age-matched naive controls, whereas radically drug-cured, previously patently-infected cattle were not. Experimental infections with O. ochengi have revealed the kinetics of the immune response in relation to parasite development and demonstrate analogous responses to those reported in O. volvulus infection in humans and chimpanzees. In an immunization experiment with irradiated L3 larvae, cattle were significantly protected against experimental challenge--the first such demonstration of the experimental induction of immunity in a natural Onchocerca host-parasite system. Taken collectively, these studies not only demonstrate the similarity between the host-parasite relationships of O. ochengi in cattle and O. volvulus in humans, but promise to advance options for the control of human onchocerciasis.

Entities:  

Mesh:

Year:  2000        PMID: 10874716     DOI: 10.1017/s0031182099005788

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  25 in total

1.  Influence of dyslipidemia on moxidectin distribution in plasma lipoproteins and on its pharmacokinetics.

Authors:  Mohamad Firas Bassissi; Michel Alvinerie; Pascal Guy Pierre Martin; Bertrand Perret; Anne Lespine
Journal:  Pharm Res       Date:  2006-09-15       Impact factor: 4.200

Review 2.  A comprehensive, model-based review of vaccine and repeat infection trials for filariasis.

Authors:  C Paul Morris; Holly Evans; Sasha E Larsen; Edward Mitre
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  A virus-free poly-promoter vector induces pluripotency in quiescent bovine cells under chemically defined conditions of dual kinase inhibition.

Authors:  Ben Huang; Tong Li; Lucia Alonso-Gonzalez; Ruben Gorre; Sarah Keatley; Andria Green; Pavla Turner; Prasanna Kumar Kallingappa; Vinod Verma; Björn Oback
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

4.  Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.

Authors:  Saskia I Johanns; Richard G Gantin; Bawoubadi Wangala; Kossi Komlan; Wemboo A Halatoko; Meba Banla; Potchoziou Karabou; Adrian Jf Luty; Hartwig Schulz-Key; Carsten Köhler; Peter T Soboslay
Journal:  PLoS Negl Trop Dis       Date:  2022-05-03

5.  Repeated high doses of avermectins cause prolonged sterilisation, but do not kill, Onchocerca ochengi adult worms in African cattle.

Authors:  Barend M deC Bronsvoort; Alfons Renz; Virginia Tchakouté; Vincent N Tanya; David Ekale; Alexander J Trees
Journal:  Filaria J       Date:  2005-08-08

6.  River blindness: a success story under threat?

Authors:  María-Gloria Basáñez; Sébastien D S Pion; Thomas S Churcher; Lutz P Breitling; Mark P Little; Michel Boussinesq
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

7.  Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination.

Authors:  W S Alley; G J van Oortmarssen; B A Boatin; N J Nagelkerke; A P Plaisier; J H Remme; J Lazdins; G J Borsboom; J D Habbema
Journal:  BMC Public Health       Date:  2001-11-06       Impact factor: 3.295

8.  Selective activity of extracts of Margaritaria discoidea and Homalium africanum on Onchocerca ochengi.

Authors:  Fidelis Cho-Ngwa; Melanie Abongwa; Moses N Ngemenya; Kennedy D Nyongbela
Journal:  BMC Complement Altern Med       Date:  2010-10-28       Impact factor: 3.659

Review 9.  Of mice, cattle, and humans: the immunology and treatment of river blindness.

Authors:  Judith E Allen; Ohene Adjei; Odile Bain; Achim Hoerauf; Wolfgang H Hoffmann; Benjamin L Makepeace; Hartwig Schulz-Key; Vincent N Tanya; Alexander J Trees; Samuel Wanji; David W Taylor
Journal:  PLoS Negl Trop Dis       Date:  2008-04-30

10.  Anti-Onchocerca activity and phytochemical analysis of an essential oil from Cyperus articulatus L.

Authors:  Jonathan Alunge Metuge; Kennedy D Nyongbela; James A Mbah; Moses Samje; Ghislain Fotso; Smith B Babiaka; Fidelis Cho-Ngwa
Journal:  BMC Complement Altern Med       Date:  2014-07-07       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.